Çapraz Tasarımlarda Etkilerin Testi için Parametrik ve Parametrik Olmayan Testlerin Karşılaştırılması
Öz
Anahtar kelimeler
Tam metin:
PDFDOI: http://dx.doi.org/10.19113/sdufbed.83451
Referanslar
[1] Armaneri, Ö., Armaneri, S., 2006. Crossover tasarımların klinik araştırmalarda uygulaması, Fen ve Mühendislik Dergisi, 8(3):51-64.
[2] McNair, D. M., 1971. Antianxiety drugs and human performance, Archives of General Psychiatry, 29(5), 611-617.
[3] Jones, B., Kenward, M.G., 1989. Design and analysis of cross-over trial. USA: Chapman and Hall, 1-89.
[4] Yılmaz, L., Bayrak, H., Gökpınar, F., 2016. İki işlem üçperiyot dual dengeli tasarımların nesne düşüşlerine sağlamlığının değerlendirilmesi, SDU, Fen bilimleri Enstitüsü Dergisi, 20(1), 1-7.
[5] Bandyopadhyay, U., Chatterjee, S., 2015. Nonparametric analysis of the two-period two treatment crossover design, Journal of Nonparametric Statistics, 27(1), 127-148.
[6] Basu, J., Bandyopadhyay, U., Dutta, G., 2017. Nonparametric testing under crossover design for ordered categorical response, Journal of the Korean Statistical Society.
[7] Jones, B., Kenward, M.G., 2014. Design and analysis of cross-over trials, CRC press.
[8] Cleophas, T.J.M., Zwinderman, A.H., 2002. Crossover studies with continuous variables: power analysis, American Journal of Therapeutics, 9, 69-73.
[9] Yıldırım, D.D., Taşdelen, B., 2013. AB/BA çapraz geçişli denemelerinde tip I hata oranı ile ilişkili faktörler, Türkiye Klinikleri J Biostat, 5(2), 61-68.
[10] Uriarte, R.D., 2002. Incrrect analysis of crossover trials in animal behavior research, Animal Behaviour, 63, 815-822.
[11] Elbourne, D.R., Altman, D.G., Higgins, J.P.T., Curtin, F., Worthington, H.V., Vail, A., 2002. Meta-analyses involving cross-over trials: methodological issues, International Journal of Epidemiology, 31, 140-149.
[12] Hills, M., Armitage, P., 1979. The two-period cross-over clinical trial, British Journal of Clinical Pharmacology, 8, 7-20.
[13] Brown, B.W., 1980. The crossover experiment for clinical trials, Biometrics, 36(1), 69-79.
[14] Bellavance, F., Tardif, S., 1995. A nonparametric approach to the analysis of three-treatment three- period crossover design, Biometrika, 82(4), 865-875.
[15] Öhrvik, J., 1998. Nonparametric methods in crossover trials, Biometrical Journal, 40(7), 771-789.
[16] Putt, M.E., Chinchilli, V.M., 2004. Nonparametric approaches to the analysis of crossover studies, Statistical Science, 19(4), 712-719.
[17] Cleophas, T.J., 1999. Clinical trials: relevance of correlation between treatment responses, Clin Research & Reg Affairs, 16(4), 193-204.
[18] Senn, S., 2002. Cross-over trials in clinical research, second edition. England: John Wiley & Sons, 1-157.
[19] Grizzle, J.E., 1965. The two-period change-over design and its use in clinical trials, Biometrics, 2, 469-480.
[20] Reed, J.F., 2004. Analysis of two-treatment, two-period crossover trials in emergency medicine, Annals of Emergency Medicine, 43(1), 54-58.
[21] Toutenburg, H., 2002. Statistical analysis of designed experiments, second edition, New York: Springer, 341-384.
[22] Gacula, M. C., 1993. Design and Analysis of Sensory Optimization, USA: Food and Nutrition Press, 45-46.
This work is licensed under a Creative Commons Attribution 4.0 License.
e-ISSN: 1308-6529


